Key result
Resveratrol cuts endothelial NF-kappaB activation >50%, attenuating monocyte adhesion and inflammatory expression.
Answers are grounded in this paper and cite their sources.
Epidemiological studies suggest that Mediterranean diets rich in resveratrol are associated with reduced risk of coronary artery disease. However, the mechanisms by which resveratrol exerts its cardioprotective effects are not completely understood. Because TNF-alpha-induced endothelial activation and vascular inflammation play a critical role in vascular aging and atherogenesis, we evaluated whether resveratrol inhibits TNF-alpha-induced signal transduction in human coronary arterial endothelial cells (HCAECs). We found that TNF-alpha significantly increased adhesiveness of the monocytic THP-1 cells to HCAECs, an effect that could be inhibited by pretreatment with resveratrol and the NF-kappaB inhibitor pyrrolidine dithiocarbamate. Previously, we found that TNF-alpha activates NAD(P)H oxidases, and our recent data showed that TNF-alpha-induced endothelial activation was prevented by the NAD(P)H oxidase inhibitor apocynin or catalase plus SOD. Resveratrol also inhibited H(2)O(2)-induced monocyte adhesiveness. Using a reporter gene assay, we found that, in HCAECs, TNF-alpha significantly increased NF-kappaB activity, which could be inhibited by resveratrol (>50% inhibition at 10(-6) mol/l) and pyrrolidine dithiocarbamate. Resveratrol also inhibited TNF-alpha-induced, NF-kappaB-driven luciferase expression in rat aortas electroporated with the reporter gene construct. In TNF-alpha-treated HCAECs, resveratrol (in the submicromolar range) significantly attenuated expression of NF-kappaB-dependent inflammatory markers inducible nitric oxide synthase, IL-6, bone morphogenetic protein-2, ICAM-1, and VCAM. Thus resveratrol at nutritionally relevant concentrations inhibits TNF-alpha-induced NF-kappaB activation and inflammatory gene expression and attenuates monocyte adhesiveness to HCAECs. We propose that these anti-inflammatory actions of resveratrol are responsible, at least in part, for its cardioprotective effects.
No takes yet. Share an insight, caveat, or question.
Csiszár et al. (2006) studied TNF-alpha-induced endothelial activation and vascular inflammation. Resveratrol vs. Untreated TNF-alpha-induced control and pyrrolidine dithiocarbamate (NF-kappaB inhibitor) was evaluated on TNF-alpha-induced NF-kappaB activity, monocyte adhesiveness to HCAECs, and inflammatory marker expression. Resveratrol inhibited TNF-alpha-induced NF-kappaB activity by >50% at 10(-6) mol/l and attenuated monocyte adhesiveness and inflammatory gene expression in HCAECs.
Synapse has enriched 10 related papers. Consider them for comparative context: